Evaluation of warfarin management in primary health care centers in Qatar: A retrospective cross-sectional analysis of the national dataset.

Alshihab, S ; Mohamed Ibrahim, MI ; et al.

In: Current problems in cardiology, Jg. 49 (2024-04-01), Heft 4, S. 102427

Online academicJournal

Zugriff:

Zum Volltext

Background: Warfarin management is associated with severe complications, highlighting the critical need to evaluate the quality of its administration.

Objectives: To evaluate the quality of warfarin management for patients managed in primary healthcare centers by measuring the percentage of Time in Therapeutic Range (TTR) and the proportion of extreme out-of-range international normalized ratio (INR) values.

Methods: This is a cross-sectional study. Data was extracted from a national dataset retrieved from the largest primary healthcare provider in Qatar. TTR was calculated using the traditional method. Inferential and descriptive analyses were performed as appropriate.

Results: Four hundred ninety-four patients met the inclusion criteria. The mean (SD) TTR was 45.3 % (17.5). This was significantly lower than the recommended cutoff value (P<0.001). Extreme out-of-range INR accounted for 24.7 % of total INR readings.

Conclusions: The management of patients taking warfarin in Qatar is inadequate. More effective strategies are warranted to ensure safe and effective therapy.

Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Titel:	Evaluation of warfarin management in primary health care centers in Qatar: A retrospective cross-sectional analysis of the national dataset.
Autor/in / Beteiligte Person:	Alshihab, S ; Mohamed Ibrahim, MI ; Hadi, MA ; Syed, A ; Arabi, A ; Al-Qahtani, A ; Almujalli, H ; Rafie, I ; Al-Kuwari, MG ; Kandy, M ; Al-Zaidan, M
Link:	Zum Volltext
Zeitschrift:	Current problems in cardiology, Jg. 49 (2024-04-01), Heft 4, S. 102427
Veröffentlichung:	[Amsterdam] : Elsevier ; <i>Original Publication</i>: Chicago, Year Book Medical Publishers., 2024
Medientyp:	academicJournal
ISSN:	1535-6280 (electronic)
DOI:	10.1016/j.cpcardiol.2024.102427
Schlagwort:	Humans Cross-Sectional Studies Anticoagulants adverse effects Retrospective Studies Qatar epidemiology Primary Health Care Warfarin adverse effects Atrial Fibrillation complications
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article; Review Language: English [Curr Probl Cardiol] 2024 Apr; Vol. 49 (4), pp. 102427. <i>Date of Electronic Publication: </i>2024 Jan 30. MeSH Terms: Warfarin* / adverse effects ; Atrial Fibrillation* / complications ; Humans ; Cross-Sectional Studies ; Anticoagulants / adverse effects ; Retrospective Studies ; Qatar / epidemiology ; Primary Health Care Contributed Indexing: Keywords: Anticoagulants; Primary health care; Time in therapeutic range; Warfarin Substance Nomenclature: 5Q7ZVV76EI (Warfarin) ; 0 (Anticoagulants) Entry Date(s): Date Created: 20240201 Date Completed: 20240304 Latest Revision: 20240304 Update Code: 20240304

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.